XML 30 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (unaudited) - CAD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating Activities        
Net Earnings (Loss) $ 1,286 $ 820 $ 2,996 $ 2,996
Depreciation, Depletion and Amortization 1,322 1,218 3,820 3,646
Deferred Income Tax Expense (Recovery) (327) (46) (520) (124)
Unrealized (Gain) Loss on Risk Management (19) 7 (65) 31
Unrealized Foreign Exchange (Gain) Loss 153 (108) (248) 101
Realized Foreign Exchange (Gain) Loss on Non-Operating Items 4 0 4 0
(Gain) Loss on Divestiture of Assets (106) (17) (109) (121)
Re-measurement of Contingent Payments 0 0 0 30
Unwinding of Discount on Decommissioning Liabilities 63 56 179 169
(Income) Loss From Equity-Accounted Affiliates (9) (11) (45) (48)
Distributions Received From Equity-Accounted Affiliates 27 15 110 133
Stock-Based Compensation, Net of Payments 75 (13) 94 (143)
Other (3) 39 (19) (107)
Settlement of Decommissioning Liabilities (94) (74) (198) (170)
Net Change in Non-Cash Working Capital (241) 588 (179) 813
Cash From (Used in) Operating Activities 2,131 2,474 5,820 7,206
Investing Activities        
Acquisitions, Net of Cash Acquired (7) (4) (236) (19)
Capital Investment (1,154) (1,346) (3,547) (3,537)
Proceeds From Divestitures 0 22 13 47
Net Change in Investments and Other 4 1 (9) (63)
Net Change in Non-Cash Working Capital (159) 19 (260) (41)
Cash From (Used in) Investing Activities (1,316) (1,308) (4,039) (3,613)
Net Cash Provided (Used) Before Financing Activities 815 1,166 1,781 3,593
Financing Activities        
Net Issuance (Repayment) of Short-Term Borrowings 86 (35) 152 (74)
Repayment of Long-Term Debt (183) 0 (195) 0
Principal Repayment of Leases (89) (74) (266) (219)
Net Proceeds (Repayment) on Repurchase Agreements (45) 0 183 0
Common Shares Issued Under Stock Option Plans 5 1 12 51
Purchase of Common Shares Under NCIB (918) (732) (1,281) (1,337)
Purchase of Common Shares Under Employee Benefit Plan (21) 0 (94) 0
Redemption of Preferred Shares 0 0 (350) 0
Proceeds From Exercise of Warrants 2 8 5 25
Dividends Paid (356) (338) (1,057) (1,203)
Other 0 (5) 0 (7)
Cash From (Used in) Financing Activities (1,519) (1,175) (2,891) (2,764)
Effect of Foreign Exchange on Cash and Cash Equivalents 42 (41) (82) 48
Increase (Decrease) in Cash and Cash Equivalents (662) (50) (1,192) 877
Cash and Cash Equivalents, Beginning of Period 2,563 3,154 3,093 2,227
Cash and Cash Equivalents, End of Period $ 1,901 $ 3,104 $ 1,901 $ 3,104